Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × plerixafor × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Warts 1 Neutropenia 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Leukopenia 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Infections 1 Immunologic Deficiency Syndromes 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Agammaglobulinemia 1 Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 6 Etoposide 4 Prednisone 3 Doxorubicin 3 romidepsin 2 pembrolizumab 2 etoposide phosphate 2 Vincristine 2 Melphalan 2 Brentuximab Vedotin 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 sodium-iodide symporter 1 ruxolitinib 1 prednylidene 1 glofitamab 1 fludarabine phosphate 1 fludarabine 1 duvelisib 1 deltacortene 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡